ATE331789T1 - Selbsterhaltender lactococcus stamm - Google Patents

Selbsterhaltender lactococcus stamm

Info

Publication number
ATE331789T1
ATE331789T1 AT02740565T AT02740565T ATE331789T1 AT E331789 T1 ATE331789 T1 AT E331789T1 AT 02740565 T AT02740565 T AT 02740565T AT 02740565 T AT02740565 T AT 02740565T AT E331789 T1 ATE331789 T1 AT E331789T1
Authority
AT
Austria
Prior art keywords
self
supporting
lactococcus
survive
lactococcus strain
Prior art date
Application number
AT02740565T
Other languages
German (de)
English (en)
Inventor
Lothar Steidler
Original Assignee
Vlaams Interuniv Inst Biotech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vlaams Interuniv Inst Biotech filed Critical Vlaams Interuniv Inst Biotech
Application granted granted Critical
Publication of ATE331789T1 publication Critical patent/ATE331789T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1003—Transferases (2.) transferring one-carbon groups (2.1)
    • C12N9/1007—Methyltransferases (general) (2.1.1.)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y201/00—Transferases transferring one-carbon groups (2.1)
    • C12Y201/01—Methyltransferases (2.1.1)
    • C12Y201/01045—Thymidylate synthase (2.1.1.45)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
AT02740565T 2001-05-03 2002-05-03 Selbsterhaltender lactococcus stamm ATE331789T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01201631 2001-05-03
EP01204785 2001-12-07

Publications (1)

Publication Number Publication Date
ATE331789T1 true ATE331789T1 (de) 2006-07-15

Family

ID=26076897

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02740565T ATE331789T1 (de) 2001-05-03 2002-05-03 Selbsterhaltender lactococcus stamm

Country Status (9)

Country Link
EP (1) EP1383897B1 (cg-RX-API-DMAC7.html)
JP (2) JP4347575B2 (cg-RX-API-DMAC7.html)
AT (1) ATE331789T1 (cg-RX-API-DMAC7.html)
AU (1) AU2002314040B2 (cg-RX-API-DMAC7.html)
CA (1) CA2446776C (cg-RX-API-DMAC7.html)
DE (1) DE60212825T2 (cg-RX-API-DMAC7.html)
DK (1) DK1383897T3 (cg-RX-API-DMAC7.html)
ES (1) ES2266515T3 (cg-RX-API-DMAC7.html)
WO (1) WO2002090551A2 (cg-RX-API-DMAC7.html)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7780961B2 (en) 2001-05-03 2010-08-24 Actogenix N.V. Self-containing Lactococcus strain
JP2005529622A (ja) 2002-06-19 2005-10-06 ヴェーイーベー・ヴェーゼットウェー 腸吸収を促進するための方法および手段
WO2004056850A2 (en) * 2002-12-19 2004-07-08 Vib Vzw Mutant proteins showing increased secretion
JP4589618B2 (ja) * 2003-11-28 2010-12-01 独立行政法人農業生物資源研究所 免疫調節性機能を誘導する乳酸菌類とその成分
US9200249B2 (en) 2004-08-20 2015-12-01 Actogenix N.V. Method to improve Lactococcus preservation
US8748126B2 (en) * 2005-11-29 2014-06-10 Actogenix N.V. Induction of mucosal tolerance to antigens
EP2097452A1 (en) * 2006-12-14 2009-09-09 Actogenix N.V. Delivery of binding molecules to induce immunomodulation
CN101605900B (zh) 2007-01-12 2014-04-23 阿克图杰尼斯公司 乳球菌启动子和其用途
EP2125010B1 (en) 2007-01-25 2014-06-04 Actogenix N.V. Treatment of immune disease by mucosal delivery of antigens using genetically modified lactobacillus
WO2010034844A1 (en) * 2008-09-29 2010-04-01 Actogenix N.V. Reduced colonization of microbes at the mucosa
CA2837634C (en) 2011-06-01 2021-12-14 Actogenix Nv Polycistronic expression system for bacteria
RU2653757C2 (ru) 2011-09-23 2018-05-14 Интрексон Актобиотикс Н.В. Модифицированные грамположительные бактерии и их применение
ES2676707T3 (es) 2011-09-23 2018-07-24 Intrexon Actobiotics Nv Bacterias gram positivas modificadas y usos de las mismas
US9688967B2 (en) 2014-12-05 2017-06-27 Synlogic, Inc. Bacteria engineered to treat diseases associated with hyperammonemia
US20160206666A1 (en) 2014-12-22 2016-07-21 Synlogic, Inc. Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tighten gut mucosal barrier
RU2017130462A (ru) * 2015-03-02 2019-04-02 Синлоджик, Инк. Бактерия, созданная для лечения заболеваний, облегчаемых при уменьшении воспаления кишечника и/или укреплении мукозного барьера кишечника
CN106148254B (zh) * 2015-03-26 2019-11-12 南京华贞生物医药科技有限公司 一种用于减肥降脂的转化体及其构建方法与应用
SG10202003100XA (en) 2015-05-13 2020-05-28 Synlogic Operating Co Inc Bacteria Engineered to Reduce Hyperphenylalaninemia
US11685925B2 (en) 2015-10-30 2023-06-27 Synlogic Operating Company, Inc. Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tightened gut mucosal barrier
ES2925049T3 (es) 2015-11-16 2022-10-13 Synlogic Operating Co Inc Bacterias manipuladas para reducir la hiperfenilalaninemia
WO2017122180A1 (en) 2016-01-14 2017-07-20 Intrexon Actobiotics N.V. Compositions and methods for the treatment of type 1 diabetes
CA3035151A1 (en) 2016-09-02 2018-03-08 Intrexon Actobiotics N.V. Genetically modified bacteria stably expressing il-10 and insulin
IL265177B2 (en) 2016-09-13 2025-01-01 Intrexon Actobiotics N V A microorganism that adheres to the mucosa
WO2020075171A1 (en) 2018-10-11 2020-04-16 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Bacteria expressing single chain antibodies against toll-like receptors
CN114761028A (zh) 2019-09-27 2022-07-15 英特瑞克斯顿阿克图比奥帝克斯有限公司 乳糜泻的治疗
JP2023518184A (ja) 2020-03-20 2023-04-28 シンロジック オペレーティング カンパニー インコーポレイテッド 高フェニルアラニン血症を軽減するように遺伝子改変された微生物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4231764A1 (de) * 1992-09-23 1994-03-24 Inst Pflanzengenetik & Kultur Verfahren zur chromosomalen Integration eines Produkt-Gens

Also Published As

Publication number Publication date
CA2446776A1 (en) 2002-11-14
JP2004533246A (ja) 2004-11-04
EP1383897B1 (en) 2006-06-28
WO2002090551A3 (en) 2003-03-27
JP2009060913A (ja) 2009-03-26
EP1383897A2 (en) 2004-01-28
AU2002314040B2 (en) 2007-06-28
CA2446776C (en) 2011-07-12
DE60212825T2 (de) 2007-01-11
DE60212825D1 (de) 2006-08-10
JP4347575B2 (ja) 2009-10-21
WO2002090551A2 (en) 2002-11-14
DK1383897T3 (da) 2006-10-30
ES2266515T3 (es) 2007-03-01

Similar Documents

Publication Publication Date Title
ATE331789T1 (de) Selbsterhaltender lactococcus stamm
DE602005022740D1 (de) Amplifikationsblocker umfassend interkalierende nukleinsäuren (ina) enthaltend interkalierende pseudonukleotide (ipn)
WO2004046346A3 (en) Self-containing lactobacillus strain
PL1668001T3 (pl) Podstawione heteroarylobenzofuranowe kwasy
DE60228251D1 (de) Prepreg, verbundmaterial und ihre anwendungen
WO2006017420A3 (en) Document processing and management approach to making changes to a document and its representation
ATE363893T1 (de) Amphotere liposomen und verwendung dieser
ATE286060T1 (de) Präpolymere (meth)acrylate mit polycyclischen oder aromatischen segmenten
HRP20050705B1 (hr) Ekspresijski vektor koji sadrži promotor mcmv ie2
SE0004420L (sv) Förstärkare
ATE341606T1 (de) Natriumpercarbonatpartikel mit verbesserter lagerstabilit t
ATE468627T1 (de) Disc-monopol-antennenstruktur
AU2003218099A1 (en) Modulation of the immune response through the manipulation of arginine levels
DE60141141D1 (de) Mechanismus zur implementierung einer transparenten z-komprimierung
AU2001263269A1 (en) Long wavelength engineered fluorescent proteins
AU2003214098A1 (en) Ceramic colorants in the form of nanometric suspensions
TW200708929A (en) Opposite-phase scheme for peak current reduction
BR0101695A (pt) Grão abrasivo melhorado
AU2003206926A1 (en) Cultivation method for micro-organisms and bioreactor
AU2003245134A1 (en) Oxytocin as cardiomyogenesis inducer and uses thereof
DE60204778D1 (de) Zweidimensionale pyramidenfilterarchitektur
WO2001068846A3 (en) Transcription activator of the cited family
ATE402998T1 (de) D-hydantoinase aus ochrobactrum anthropi
FI20020600A0 (fi) Harava
AU2003294162A1 (en) Inter-application control to improve the performance of playback of stored interactive-tv applications

Legal Events

Date Code Title Description
EEIH Change in the person of patent owner
UEP Publication of translation of european patent specification

Ref document number: 1383897

Country of ref document: EP